Dupilumab-Treated Patients With Prurigo Nodularis Report Disease Control and Treatment Satisfaction: 6-Month Results From the RELIEVE-PN Study. J of Skin 2025, 9 (6), s716. https://doi.org/10.25251/h522p595.